Post Genome, Celera Now Shoots for Profits# Biology - 生物学
C*n
1 楼
From Fortune Feb. 19 2001
By Brian O'Keefe
Technicians are working to find drug applications from Celera's database.
Brian O'Keefe
Last year Celera Genomics and its president, J. Craig Venter, shook up the s
cientific world by successfully sequencing the human genome faster than anyo
ne—even Venter—had predicted. But when the hype faded, investors were left
with one big question: How could Celera turn its accomplishment into financ
ial gain?
The answer wasn't immediately clear. Venter insisted t
By Brian O'Keefe
Technicians are working to find drug applications from Celera's database.
Brian O'Keefe
Last year Celera Genomics and its president, J. Craig Venter, shook up the s
cientific world by successfully sequencing the human genome faster than anyo
ne—even Venter—had predicted. But when the hype faded, investors were left
with one big question: How could Celera turn its accomplishment into financ
ial gain?
The answer wasn't immediately clear. Venter insisted t